Member Info for SCC06

Slowly going in the right direction now helped by the 50/100k buys compared to 50/100k sells, seen the last couple of days. Glad I’m in before RNS detailing plans of phase 3 signalling approval from FDA or CIPD partnership.

Agreed it does offer very good value at this sp for the potential they now have. Been hard to buy in quantity this afternoon for some reason often going NT. Happy to wait to see how it unfolds

Couldn’t agree more. This will come good and soon imo

Now blue as well

Books completely changed as well for the better if your invested

This share was touching 6p before yesterdays news and now it’s at 7.5p with green light for phase 3. I think it’s worth more

Would also say that the new team are doing a good job pushing all pipelines along

Well hindsight’s a great thing but still happy I averaged down at 9p yesterday. Not much on ask sub 7.5p and if it does go sub 7p it won’t stay their long. Happy to wait for phase 3 trials to be planned and hopefully some CIPD partners announced as their in dissuasions with 2.

I do agree and this happens on news with many smaller companies, if not most. Imm wasn’t £1.50 before for no reason though and that same prize is still their albeit closer. Phase 3 trials do take time - planning, outsourcing of different phases in life and bio analytical etc etc but this is closer to marketing the drug with more of the work done. I’m sure Alora wouldn’t still be involved if they see no future.

The last placing was at 11p so can’t understand why Lanstead would be selling around 8-9p. Maybe I’m missing something. Yes Alora have the exclusive rights for the US but IMM has the rest of the world.

What I also take from todays news is safety as the control group got 800mg directly administered into the systemic system, with no effects. This data will also allow a more informative dose level selection for phase 3 trials. No surprises from another human trial which is good news. The data package for p140 must be pretty comprehensive now with all official bodies, FDA/MHRA, having scrutinised it and any questions answered. Game on id say. Isn’t this company now in the best position it’s ever been, I think it is that’s why I averaged down today

It shows the effect of the body on the drug and firms up all the associated PK data. This is what the FDA wanted

NT at 9 now, lol. Back to 50p

trot back to 50p imo

Currently under the radar. Even valeura on tsx is ca.35p

Annoyingly so

Your right, Trying for a few more but no chance

Taken a modest £3k to start, definitely looks good prospects and critically at the right time

Now into the 0.3’s

Certainly some nice sized buys today